Abstract
It is difficult to know where to begin an essay on the problem of immunological discrimination between “self” and “nonself” and the paradoxes created for this discrimination by the phenomenon of autoimmunity. As Sherlock Holmes once commented, “These are much deeper waters than I had thought.” [1] Much of my subject is mysterious not only to me but apparently to everyone who has investigated it. Therein lies a clue. The subject itself is a mystery, and therefore calls for the approach of the mystery writer. But this “who done it” differs from most in drawing its characters not only from the human society, but from the animal, microbial, cellular, and even chemical realms as well. I will trace, as novelists are wont to do, their lineage, their personal histories and, of course, their interactions. As a result, this is not the usual story of autoimmunity that is laid out in the few histories of the field that exist [2] or in textbook accounts, especially since I have focused upon the contradictions and paradoxes inherent in our current knowledge, and the gaps in it, rather than upon the myriad facts and inadequate explanations that are the usual fare. But my approach has its inadequacies, too. Most importantly, it provides no conclusion; only clues. I can only hope that, perhaps, if the plot is devised properly, some budding Sherlock Holmes will perceive the importance of the clues that even the writer overlooks.
Paradoxes play a key role in the advancement of science. They are associated with excitement, and with the knowledge that we must be looking at something the wrong way. The clear formulation of a paradox can herald important advances, since the resolution of the paradox is generally a conceptual step forward. It is therefore of paramount importance to identify paradoxes and focus attention on them. G.W. Hoffmann, J.G. Levy, and G.T. Nepom, Paradoxes in Immunology, 1986.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Notes
Doyle, A.C. The memoirs of Sherlock Holmes. New York: Pebbles Press, c. 1975.
Silverstein, A.M. A History of Immunology. San Diego: Academic Press, 1989
Cruse, J.M., Whitcome, D., and Lewis, R.E. Autoimmunity — historical perspective. Concepts Immunopathol. 1: 32–71, 1985
Eyquem, A. L’Immuno-pathologie de l’auto-immunisation. Archs. Inst. Pasteur, Tunis. 58: 281–295, 1981.
Ehrlich, P. and Morgenroth, J. Zur Theorie der Lysinwirkung. Berl. Klin. Wochenschr. 36: 6–21, 1899
Ehrlich, P. and Morgenroth, J. Üeber Haemolysine (5 part paper). Berl. Klin. Wochenschr. 36: 481–493, 1899
Ehrlich, P. and Morgenroth, J. Üeber Haemolysine (5 part paper). Berl. Klin. Wochenschr. 37: 453–466, 1899
Ehrlich, P. and Morgenroth, J. Üeber Haemolysine (5 part paper). Berl. Klin. Wochenschr. 37 681–696, 1900
3e. Ehrlich, P. and Morgenroth, J. Üeber Haemolysine (5 part paper). Berl. Klin. Wochenschr. 38: 251–268, 569–601, 1901. Reprinted and translated in Ehrlich, P. F The Collected Papers of Paul Ehrlich, Vol. 2. New York: Pergamon, 1957.
Cruse, J.M., Lewis, R.E., Jr. Contemporary concepts of autoimmunity. Concepts Immunopathol. 1: 1–31, 1985.
Beutner, E.H., Chorzelski, T.P., Binder, W.L. Nature of autoimmunity: pathologic versus physiologic responses and a unifying concept. In Beutner, E.H., Chorzelski, T.P., and Bean, R. Immunopathology of the Skin 2nd ed. New York, Wiley, 1979, pp. 147–180.
Ehrlich, P. and Morgenroth, J. Berl. Klin. Wochenschr. 28: 251–268, 1901; Collected Papers, p. 253.
Silverstein, A.M. A History of Immunology. San Diego: Academic Press, 1989 162–163
Goltz, D. Das Donath-Landsteiner Haemolysin. Die Entstehung eines Mythos in der Medizin des 20. Jahrhunderts. Clio. Med. 16: 193–211,1982.
Metalnikoff, S. Etudes sur la spermatoxine. Ann. Inst. Pasteur, Paris. 14: 577–603, 1900; Ehrlich and Morgenroth, 1901, 251 and Collected Papers, p. 253n.
Donath, J. and Landsteiner, K. Üeber paroxysmale Haemaglobinurie. Muench. med. Wschr. 51: 1590–1593, 1904;
Silverstein, A.M., A History of Immunology. San Diego: Academic Press, 1989, 190–213;
Goltz, D. Das Donath-Landsteiner Haemolysin. Die Entstehung eines Mythos in der Medizin des 20. Jahrhunderts. Clio. Med. 16: 193–211, 1982.
Silverstein, A.M. A History of Immunology. San Diego: Academic Press, 1989 (note 2)
Cruse, J.M., Whitcome, D., and Lewis, R.E. Autoimmunity — historical perspective. Concepts Immunopathol. 1: 32–71, 1985
Glynn, L.E., Holborow, E.J. Autoimmunity and Disease Oxford: Blackwell, 1965
Mackay, I.R., Burnet, F.M. Autoimmune Diseases Springfield, IL: CC Thomas, 1963
Cohen, I.R. The self, the world, and autoimmunity. Sci. Am. 52–61, April 1988
Sinha, A.A., Lopez, M.T., McDivitt, H.O. Autoimmune diseases: the failure of self tolerance. Science 248: 1380–1388, 1990.
Silverstein, A.M. A History of Immunology. San Diego: Academic Press, 1989 (note 2) 172–175.
Weigle, W.O. Analysis of autoimmunity through experimental models of thryoiditis and allergic encephalomyelitis. Adv. Immunol. 30: 159–273, 1980
Waksman, B.H. Experimental allergic encephalomyelitis and the “auto-allergic” diseases. Intern. Arch. Allergy Suppl. vol. 14, 1959.
Rivers, T.M., Sprunt, D.H., Berry, G.P. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. Exp. Med. 58: 39–57, 1933
Rivers, T.M., Schwentker, F.F. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. Exp. Med. 61, 689–705, 1935;
Waksman, B.H., Adams, R.D. A histologic study of the early lesion in experimental allergic encephalomyelitis in the guinea pig and rabbit. Amer. J. Path. 41: 135–147, 1962.
Paterson, P.Y. Transfer of allergic encephlomyelitis in rats by means of lymph node cells. J. Exp. Med. 111: 119–136, 1960
Orgad, S., Cohen, I. Autoimmune encephalomyelitis: activation of thymus lymphocytes against syngeneic brain antigens in vitro. Science, 183: 1083–1085, 1974
Shiraki, H., Ohtani, S. Clinical and pathological features of rabies post-vaccinal encephalomyelitis in man. Relationship to multiple sclerosis and to experimental allergic encephalomyelitis in animals. In Allergic Encephalomyelitis, Kies, M.W. and Alvord, E.C., Jr., Eds. Springfield, Ill, Charles C. Thomas, 1959, p. 58
Waksman, B. H. Immunological aspects of multiple sclerosis (Forum) Res. Immunol. 140: 173 passim, 1990.
Freund, J., McDermott, K. Sensitization to horse serum by means of adjuvants. Proc. Soc. Exp. Biol. Med. 49: 548–553, 1942
Kabat, E.A., Wolf, A., Bezer, A.E. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J. Exp. Med. 85: 11–25, 1947
Voisin, G.A., Delaunay, A., Barber, M. Sur des lésions testiculaires provoquacutées chez le cobaye par iso- et autosensibilization. Ann. Inst. Pasteur 81: 48–72, 1951
Freund, J., Lipton, M.M., Thompson, G.E. Aspermatogenesis in the guinea pig induced by testicular tissue and adjuvants. J Exp. Med. 97: 711–726, 1953.
Freund, J. Mode of action of immunologic adjuvants. Adv. Tuberc. Res. 7: 130–148, 1956
Finger, H. Possible mechanism of adjuvant action. In: Pathogenesis and Etiology of Demyelinating Diseases. Burdzy, K. and Callos, P., Eds. Basel: Karger, 1969, pp. 293–309
Paterson, P.Y. Autoimmune neurological disease: experimental animal systems.and implications for multiple sclerosis. In: Autoimmunity: Genetic, Immunologic, Virologic, and Clinical Aspects. Talal, N., Ed. New York: Academic Press, 1977, pp. 644–692.
Rivers, T.M., Sprunt, D.H., Berry, G.P. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. Exp. Med. 58: 39–57, 1933
Gautier-Smith, P. Neurological complications of glandular fever (infectious mononucleosis). Brain 88, 323–334, 1965
Vortel, V., Plachy, V. Glial-nodule encephalitis associated with generalized cytomegalic inclusion body disease. Am. J. Clin. Pathol. 49: 319–324, 1968
Hanshaw, J. Cytomegalovirus and cerebral dysfunction. Hosp. Practice 5, 111–120, 1970
Heyworth, B., Ironside, A.G., Hewer, R.L., Leonard, J.C. et al. Polyneuritis associated with cytomegalovirus infections. Q. J. Medicine 40, 435–442, 1971
Talal, N. Autoimmunity: Genetic, Immunologic, Virologic, and Clinical Aspects, 1977
Lampert, P.W. Autimmune and virus-induced demyelinating diseases. Am. J. Pathol. 91: 176–197, 1978
Clyde, W.A. Neurological syndromes and mycoplasmal infections. Arch. Neurol. 37, 65–66, 1980
Dowling, P., Menonna, J., Cook, S. Cytomegalovirus complement fixation antibody in Guillain-Barré syndrome. Neurology (Minn.) 27, 1153–1156, 1977.
Sprent, J.F.A. Parasitism, immunity and evolution. In: The Evolution of Living Organisms. Leeper, G.W., Ed. Parkville, Victoria: Melbourne University Press, 1962, pp. 149–165.
Zabriskie, J.B. Mimetic relationships between group A streptococci and mammalian tissues. Adv. Immunol. 7: 147–188, 1967
Thornes, C.J., Morris, J.A. Common epitopes between mycobacterial and certain host tissue antigens. Clin. exp. Immunol. 61: 323–328, 1985
Heijne, G., Uhlén, M. Homology to region X from staphylococcal protein A is not unique to cell surface proteins. J. Theor. Biol. 127: 373–376, 1987
Anderson, D.C., van Schooten, W.C.A., Barry, M.E., Janson, A.A.M., Buchanan, T.M., de Vries, R.R.P A Mycobacterium leprae-specific human T-cell epitope cross-reactive with an HLA-DR2 peptide. Science. 242: 259–261, 1988
Barthomomaeus, W.N., O’Donoghue, H., Foti, D., Lawson, M., Shellam, G.R. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology 64: 397–405, 1988
Fujinami, R.S., Oldstone, M.B.A. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230: 1043–1045, 1985
Jahnke, U., Fischer, E.H., Alvord, E.C. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 229: 282–284, 1985
Fujinami, R.S., Nelson, J.A., Walker, L., Oldstone, M.B.A. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J. Virology 62: 100–105, 1988
Srinivasappa, J., Saegusa, J., Prabhakar, B.S., Gentry, M.K. et al. Molecular mimickry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J. Virology 57: 397–401, 1986
Capron, A., Dessaint, J.P., Capron, M., Ouma, J.H., Butterworth, A.E. Immunity to schistosome: progress toward vaccine. Science 238: 1065–1071, 1987.
Krueger, J.M., Pappenheimer, J.R., Karnovsky, M.L. Sleep-promoting effects of muramyl peptides. Proc. Natl. Acad. Sci. USA 79: 6102–6106, 1982
Masek, K., Kadlecova, O., Raskova, H. Brain amines in fever and sleep cycle changes caused by streptococcal mucopeptide. Neuropharmacology 12: 1039–1047, 1973
Masek, K., Kadkecova, O., Petrovicky, P. The effect of some bacterial products on temperature and sleep in rats. Z. Immun-Forsch. 149: 273–282, 1975
Root-Bernstein, R.S., Westall, F.C. Sleep factors: do muramyl peptides activate serotonin binding sites? Lancet i: 653, 1983
Root-Bernstein, R.S., Westall, F.C. Serotonin binding sites. I. Structures of sites on myelin basic protein, LHRH, MSH, and ACTH. Brain Res. Bull. 12: 425–436, 1984
Karnovsky, M.L. Muramyl peptides in mammalian tissues and their effects at the cellular level. Fed. Proc. 45: 2557–2560, 1986
Silverman, D.H.S., Imam, K., Karnovsky, M.L. Muramyl peptide/serotonin receptors in brain-derived preparations. Peptide Res. 2: 338–344, 1989
Kaydalov, A.A., Utkin, Y.N., Androva, T.M., Tsetlin, V.I., Ivanov, V.T. Muramyl peptides bind specifically to rat brain membranes. FEBS Lett. 248: 78–82, 1989.
See note 19, especially: Jahnke, U., Fischer, E.H., Alvord, E.C. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 229: 282–284, 1985;
Fujinami, R.S., Nelson, J.A., Walker, L., Oldstone, M.B.A. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J. Virology 62: 100–105, 1985.
Litvak, A.M., Sands, I.J., Gribel, H. Encephalitis complicating measles. Am. J. Dis. Child. 65: 265–273, 1943
Fenichel, G.M. Neurological complications of immunization. Ann. Neurol. 12: 119–128, 1982
Wilson, G.S. The Hazards of Immunization. London: The Athlone Press, 1967.
Jaworski, M. A., Severini, A., Mansour, G., Hennig, K. et al. Inherited diseases in North American Mennonites: Focus on Old Colony (Chortitza) Mennonites. Am. J. Med. Genetics 32: 158–168, 1989
Cruse, J.M., Lewis, R.E., Jr. Contemporary concepts of autoimmunity. Concepts Immunopathol. 1: 1–31, 1985 (note 4)
Todd, J.A., Acha-Orbea, H., Bell, J.I. et al. A molecular basis for MHC class II-associated autoimmunity. Science 240: 1003–1009, 1990.
Navia, B.A., Jordan, B.D., Price, R.W. The AIDS dementia complex: I. Clinical features. Ann. Neurology 19: 517–524, 1986
Navia, B.A., Cho, E.-S., Petito, C.K., Price, R.W. The AIDS dementia complex: II. Neuropathology. Ann. Neurol. 19: 525–535, 1986
Nunn, P.P., McAdam, K.P.W.J. Mycobacterial infections and AIDS. Brit. Med. Bull. 44: 801–813, 1988
Petito, C.K., Navia, B.A., Cho, E.-S., Jordan, B.D., George, D.C., Price, R.W. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 312: 874–879, 1985
Ryder, J.W., Croen, K., Kleinschmidt-DeMasters, B.K., Ostrove, J.M., Straus, S.E., Cohn, D.L. Progressive encephalitis three months after the resolution of cutaneous zoster in a patient with AIDS. Ann. Neurol. 19: 182–188, 1986
Shearer, G.M. Immune suppression and recognition of class II (Ia) antigens: a possible factor in the etiology of acquired immune deficiency syndrome. In AIDS: The Epidemic of Kaposi’s Sarcoma and Opportunistic Infections, Friedman-Kien, A.E. and Laubenstein, L.J., Eds. New York: Masson, 1984, pp. 169–172
Welch, K., Findkbeiner, W., Alpers, C.E. et al. Autopsy findings in acquired immune deficiency syndrome. JAMA 252: 1152–1159, 1984
Reichert, C.M., O’Leary, T.J., Levens, D.L. et al. Autopsy pathology in the acquired immune deficiency syndrome. Am. J. Pathol. 112: 357–382, 1983
Neidt, G.W., Schinella, R.A. Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies. Arch. Pathol. Lab. Med. 109: 727–734, 1985.
Reviewed in Bergstrand, H. Immunochemistry of encephalitogenic protein. In: Immunochemistry of Proteins Atassi MZ, Ed. Vol. 1. New York: Academic Press, 1977, pp. 315–370
Weigle, W.O. Analysis of autoimmunity through experimental models of thryoiditis and allergic encephalomyelitis. Adv. Immunol. 30: 159–273, 1980 (note 12)
Westall, F.C., Root-Bernstein, R.S. An explanation of prevention and suppression of experimental allergic encephalomyelitis. Mol. Immunol. 20: 169–177, 1983
Davison, A.N., Cuzner, M.L., Eds. The Suppression of Experimental Allergic Encephalomyelitis and Multiple Sclerosis. London: Academic Press, 1980
Ben-Nun, A., Wekerle, H., Cohen, I.R. The rapid isolation of clonable antigen-specific T lymphocytes lines capable of mediating autoimmune encephalitis. Eur. J. Immunol. 11: 195–199, 1981
Mitsuzawa, E., Yasuda, T., Tamura, N., Ohtani, S. Pretreatment with antigen or adjuvant, and the preventability of allergic encephalomyelitis induced by basic protein with synthetic muramyl dipeptide in comparison with Freund’s complete adjuvant. Jpn. J. Exp. Med. 54: 97–107, 1984.
Silverstein, Silverstein, A.M. A History of Immunology. San Diego: Academic Press, 1989 (note 2) 214ff.
Rivers, T.M., Schwentker, F.F. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. Exp. Med. 61, 689–705, 1935;
Waksman, B.H., Adams, R.D. A histologic study of the early lesion in experimental allergic encephalomyelitis in the guinea pig and rabbit. Amer. J. Path. 41: 135–147, 1962.
Field, E.J., Caspary, E.A. Lymphocyte sensitization: an in vitro test for cancer? Lancet ii: 1337–1371, 1970
Coates, A., McKay, I.R., Crawford, M. Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism. I. Cell. Immunol. 12: 370–381, 1974
Waksman, F.J., Fritz, R.B., Hinrichs, D.J. The presence of antigen-reactive cells during the induction, recovery, and resistance phases of EAE. Cell. Immunol. 48: 34–42, 1980.
Bergstrand, H., Kallen, B. On the statistical evaluation of the macrophage migration inhibition assay. Scand. J. Immunol. 2: 173–187, 1973
Freund, J. Mode of action of immunologic adjuvants. Adv. Tuberc. Res. 7: 130–148, 1956 Freund, op. cit. 1956 (note 16)
Mitchison, N.A. Induction of immunological paralysis in two zones of dosage. Proc. Roy. Soc. Lond. 161: 275–292, 1964/65.
Bergstrand, H., Kallen, B. On the statistical evaluation of the macrophage migration inhibition assay. Scand. J. Immunol. 2: 173–187, 1973 (note 29)
Ben-Nun, A., Wekerle, H., Cohen, I.R. The rapid isolation of clonable antigen-specific T lymphocytes lines capable of mediating autoimmune encephalitis. Eur. J. Immunol. 11: 195–199, 1981 (note 25)
Spitler, L.E., von Muller, C.M., Fudenberg, H.H., Eylar, E.H. Experimental allergie encephalitis: dissociation of cellular immunity to brain protein and disease production. J. Exp. Med. 136: 156–174, 1972
Lisak, R.R., Zweiman, B. Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis. Cell. Immunol. 14: 242–254, 1974
Bergstrand, H. Immunochemistry of encephalitogenic protein. In: Immunochemistry of Proteins Atassi, M.Z., Ed. New York: Academic Press, 1977, pp. 315–370
Lyman, W.D., Kadish, A.S., Raine, C.S. Experimental allergic encephalomyelitis in the guinea pig: variation in peripheral blood lymphocyte responsiveness to myelin basic protein during disease development. Cell. Immunol. 63: 409–416, 1981
Waksman, F.J., Fritz, R.B., Hinrichs, D.J. The presence of antigen-reactive cells during the induction, recovery, and resistance phases of EAE. Cell. Immunol. 48: 34–42, 1980.
The only cross-reactivity between myelin basic protein and mycobacteria reported — a weak skin response in guinea pigs—was by Vandenbark, A.A., Burger, D.R., Vetto, R.M. Cell-mediated immunity in experimental allergic encephalomyelitis: cross-reactivity between myelin basic protein and mycobacteria antigens. Proc. Soc. Exp. Biol. Med. 148: 1233–1236, 1975. However, the same authors also reported that lymphocyte cultures form mycobacteria-inoculated animals did not respond at all to myelin basic protein.
Ellouz, F., Adam, A., Ciorvaru, R., Lederer, E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59: 1317–1325, 1974
Nagai, Y, Akiyama, K., Suzuki, K. et al. Structural specificity of synthetic peptide adjuvant for induction of experimental allergic encephalomyelitis. Cell. Immunol. 35: 158–167, 1978
Westall, F.C., Robinson, A.B., Caccam, J., Jackson, J.M., Eylar, E.H. Essential chemical requirements for induction of allergic encephalomyelitis. Nature 229: 22–24, 1971
Carelli, C., Audibert, F., Gaillard, J., Chedid, L. Immunological castration of male mice by a totally synthetic vaccine administered in saline. Proc. Natl. Acad. Sci. USA 79: 5392–5395, 1982
Testicular fractions are also effective: Glynn, L.E., Holborow, E.J. Autoimmunity and Disease. Oxford: Blackwell, 1965, pp. 306–319.
Root-Bernstein, R.S. Structure of a serotonin and LSD binding site on myelin basic protein. J. Theor. Biol. 100: 373–378, 1983
Root-Bernstein, R.S. “Molecular sandwiches” as a basis for structural and functional similarities of interferons, MSH, ACTH, LHRH, myelin basic protein, and albumins. FEBS Lett. 168: 208–212, 1984
Root-Bernstein, R.S., Westall, F.C. Serotonin binding sites. I. Structures of sites on myelin basic protein, LHRH, MSH, and ACTH. Brain Res. Bull. 12: 425–436, 1984 (note 20).
Freund, J., Lipton, M.M., Thompson, G.E. Aspermatogenesis in the guinea pig induced by testicular tissue and adjuvants. J Exp. Med. 97: 711–726, 1948
Kabat, E.A., Wolf, A., Bezer, A.E. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J. Exp. Med. 85: 11–25, 1947 (note 15).
Shaw, C.M., Alvord, E.C., Fahlberg, W.J., Jr., Kies, M.W. Adjuvant-antigen relationships in the production of experimental allergic encephalomyelitis in guinea pigs. J. Exp. Med. 115: 169–179, 1962
Young, J.D., Tsuchiya, D., Geier, M. et al. The encephalitogenic dose-response in guinea pigs of the tryptophan region of myelin basic protein. Immunol. Commun. 3: 219–226, 1974
Nagai, Y, Akiyama, K., Suzuki, K. et al. Structural specificity of synthetic peptide adjuvant for induction of experimental allergic encephalomyelitis. Cell. Immunol. 35: 158–167, 1978 (note 31).
Salk, J., Romine, J.S., Westall, F.C., Wiederholt, W.C. Myelin basic protein studies in experimental allergic encephalomyelitis and multiple sclerosis: a summary with theoretical considerations of multiple sclerosis etiology. In: Experimental Allergic Encephalomyelitis and Multiple Sclerosis. Davison, A.N. and Cuzner, M.L., Eds. London: Academic Press, 1980, pp. 141–156
Field E. J. Immunological treatment for multiple sclerosis. Lancet i: 1272, 1989.
Carelli, C., Audibert, F., Gaillard, J., Chedid, L. Immunological castration of male mice by a totally synthetic vaccine administered in saline. Proc. Natl. Acad. Sci. USA 79: 5392–5395, 1982 (note 31)
Dyck, R.J., Thomas, P.K., Lambert, E.H., Bunge, R., eds. Peripheral Neuropathy Philadelphia: WB Saunders, 1984
Waxman, B.H., Raymond, D.A., Mansmann, H.C. Experimental study of diphtheric polyneuritis in the rabbit and guinea pig. J. Exp. Med. 105: 591–614, 1957
Weigle, W.O. Analysis of autoimmunity through experimental models of thryoiditis and allergic encephalomyelitis. Adv. Immunol. 30: 159–273, 1980 (note 12)
Brostoff, S., Burne, H.P., Lampert, P., Eylar, E.H. Nature, New Biology 235: 210–214, 1972
Wacker, W.B., Donoso, L.A., Kalsow, CM., Yankeelov, J.A. Jr., Organisciak, D.T. J. Immunol. 119: 1949, 1977
Kozak, Y., Faure, J.P., Ardy, H., Ursi, M., Thillaye, B. Ann. Immunol. (Institute Pasteur) 129C: 73–88, 1978.
Root-Bernstein, R.S. Amino acid pairing. J. Theor. Biol. 94: 885–895, 1982
Root-Bernstein, R.S., Westall, F.C. Serotonin binding sites. I. Structures of sites on myelin basic protein, LHRH, MSH, and ACTH. Brain Res. Bull. 12: 425–436, 1984 (note 32)
Root-Bernstein, R.S., Westall, F.C. Serotonin binding sites. I. Structures of sites on myelin basic protein, LHRH, MSH, and ACTH. Brain Res. Bull. 12: 425–436, 1984 (note 20).
Root-Bernstein, R.S. Discovering. Cambridge, MA.: Harvard University Press, 1989, pp. 195–196, 269–272, 309.
Westall, F.C., Root-Bernstein, R.S. An explanation of prevention and suppression of experimental allergic encephalomyelitis. Mol. Immunol. 20: 169–177, 1983 (note 25);
Root-Bernstein, R.S., Westall, F.C. Complementarity between antigen and adjuvant in the induction of autoimmune diseases — a dual antigen hypothesis. J. Infer. Deduct. Biol. 1.5: 1–25, 1986.
Westall, F.C., Root-Bernstein, R.S. An explanation of prevention and suppression of experimental allergic encephalomyelitis. Mol. Immunol. 20: 169–177, 1983 (note 25);
Root-Bernstein, R.S., Westall, F.C. Complementarity between antigen and adjuvant in the induction of autoimmune diseases — a dual antigen hypothesis. J. Infer. Deduct. Biol. 1.5: 1–25, 1986.
Westall, F.C., Root-Bernstein, R.S. Cause and prevention of postinfectious and postvaccinal neuropathies in light of a new theory of autoimmunity. Lancet ii: 251–252, 1986
Root-Bernstein, R.S. Multiple antigen mediated autoimmunity (MAMA) in AIDS: a possible model for postinfectious autoimmunity. Res. Immunol. (Institute Pasteur), 141, 815–838, 1990.
Westall, F.C., Root-Bernstein, R.S. An explanation of prevention and suppression of experimental allergic encephalomyelitis. Mol. Immunol. 20: 169–177, 1983 (note 25).
. Westall, F.C., Root-Bernstein, R.S. An explanation of prevention and suppression of experimental allergic encephalomyelitis. Mol. Immunol. 20: 169–177, 1983 (note 25).
Sinha, A.A., Lopez, M.T., McDivitt, H.O. Autoimmune diseases: the failure of self tolerance. Science 248: 1380–1388, 1990 (note 10).
Root-Bernstein, R.S., Yurochko, F., Westall, F.C. Clinical suppression of experimental allergic encephalomyelitis by muramyl dipeptide “adjuvant.” Brain Res. Bull. 17: 473–476, 1986
43b. Killen, J., Root-Bernstein, R.S., Lallouette, P., unpublished data.
See figure 1 of Suckling, A. J., Kirby, J. A., Rumsby, M.G. Characterization by acid alpha-naphthyl acetate esterase staining of the spinal cord cellular infiltrate in the acute and relapse phases of chronic relapsing experimental allergic encephalomyelitis. Prog. Brain Res. 59: 317–322, 1984
Hickey, W.F., Kimura, H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239: 290–292, 1988.
Westall, F.C., Root-Bernstein, R.S. Serotonin-binding peptides bind muramyl dipeptide. Abst. 170 Soc. Neurosci. Abst. 11: 1985
Root-Bernstein, R.S., Westall, F.C. Serotonin binding sites. II. Muramyl dipeptide binds to serotonin binding sites on myelin basic protein, LHRH, and MSH-ACTH 4–10. Brain Res. Bull. 25: 827–841, 1990.
This issue of the cause of kuru is a sensitive one. Carlton Gadjusek received a Nobel Prize for the discovery of the disease, which is usually attributed to a “slow virus” (see Gadjusek, D.C., Gibbs, C.J., Jr., Alpers, M. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature, 209: 794–796, 1966.)
Despite claims by Stanley Prusiner to have discovered this “slow virus” (see Prusiner, S.B. Prions and neurodegenerative diseases. N. Engl. J. Med. 317: 1571–1581, 1987)
his putative causative agent, “prions,” are highly controversial because they are supposedly composed only of protein (without DNA or RNA) and are also found genetically encoded in normal brain tissue. These findings suggest that these “slow viruses” or “prions” are not infectious, and, in fact, all experimental protocols require direct inoculation of brain material into the recipient animal. Thus kuru may actually be an autoimmune reaction similar to EAE. Certainly the fact that Gajdusek’s group succeeded in transmitting a Gerstmann-Straussler-like syndrome (another disease putative caused by a prion) to chimpanzees (again by inoculation) argues against there being an infectious origin for the disease, since this syndrome is known to be inherited in a manner consistent with a Mendelian dominant gene. (See Goodfield, J. Quest for the Killers. Boston: Birkhauser, 1985, ch. 1, especially p. 43)
Notably, retrovirologist Peter Duésberg has recently called into question the existence of the entire class of so-called “slow virus” agents since none has ever been isolated (see Deusberg P. Retroviruses as carcinogens and pathogens: expectations and reality. Cancer Res. 47: 1199–1220, 1987).
Pollock, T.M., Morris, J.A. Seven year survey of disorders attributed to vaccination in northwest Thames region. Lancet i: 753–757, 1983
Eylar, E.H. Antibody to chicken P2 protein in swine flu-associated Guillain-Barré syndrome. Fed. Proc. 43: 1991, 1983
Gendelman, H.E., Wolinsky, J.S., Johnson, R.T., Pressman, N.J. et al. Measles encephalomyelitis: lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelinization. Ann. Neurol. 15: 353–360, 1984.
Root-Bernstein, R.S. How scientists really think. Persp. Biol. Med. 32: 471–488, 1989
Root-Bernstein, R.S. Discovering. Cambridge, MA.: Harvard University Press,1989 (note 37).
Root-Bernstein, R.S. Multiple antigen mediated autoimmunity (MAMA) in AIDS: a possible model for postinfectious autoimmunity. Res. Immunol. (Institute Pasteur), 141, 815–838, 1990 (note 39).
Welch, K., Findkbeiner, W., Alpers, C.E. et al. Autopsy findings in acquired immune deficiency syndrome. JAMA 252: 1152–1159, 1984
Reichert, C.M., O’Leary, T.J., Levens, D.L. et al. Autopsy pathology in the acquired immune deficiency syndrome. Am. J. Pathol. 112: 357–382, 1983
Neidt, G.W., Schinella, R.A. Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies. Arch. Pathol. Lab. Med. 109: 727–734, 1985 (note 24).
Hurtenbach, U., Shearer, G.M. Germ cell-induced immune suppression in mice. Effect of inoculation of syngeneic spermatozoa on cell-mediated immune responses. J. Exp. Med. 155: 1719–1729, 1982
Mathur, S., Goust, J.-M., Williamson, H.O. et al. Cross-reactivity of sperm and T-lymphocyte antigens. Am. J. Reprod. Immunol. 1: 113–118, 1981
Richards, J.M., Bedford, J.M., Witkin, S.S. Immune response to allogenic insemination via the rectum in the rabbit. Fed. Proc. 42: 1334, 1983
Witkin, S.S., Sonnabend, J. Immune responses to spermatozoa in homosexual men. Fertil. Steril. 39: 337–342, 1983
Mavligit, G.M., Talpaz, M., Hsia, F.T. et al. Chronic immune stimulation by sperm alloantigens. Support for the hypothesis that spermatazoa induce immune dysregulation in homosexual males. JAMA 251(2): 237–241, 1984
Mathur, S., Goust, J.-M., Williamson, H.O. et al. Cross-reactivity of sperm and T-lymphocyte antigens. Am. J. Reprod. Immunol. 1: 113–118, 1981
Marcus, Z.H., Lunenfeld, B., Weissenberg, R., Lewin, L.M. Immunosuppressant material in human seminal fluid. Inhibition of blast transformation and of NK activity by seminal fluid patients of a male infertility clinic. Gynecol. Obstet. Invest. 23: 54–59, 1987
Williamson, J.D. Semen polyamines in AIDS pathogenesis. Nature 310: 103, 1984.
Lewis, J.H. The antigenic relationship of the alcohol-soluble fractions of brain and testicle. J. Immunol. 26: 473–478, 1934.
Root-Bernstein, R.S. Multiple antigen mediated autoimmunity (MAMA) in AIDS: a possible model for postinfectious autoimmunity. Res. Immunol. (Institute Pasteur), 141, 815–838, 1990 (note 39).
Cohen, I.R. The self, the world, and autoimmunity. Sci. Am. 52–61, April 1988 (note 10); personal observations of the author.
Fowler, W.M. Hematology 2nd ed., New York: Paul B. Hóeber, 1949, pp. 230–232.
Weisman, H.F., Bartow, T., Leppo, M. et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146–151, 1990.
Silverstein, A.M. A History of Immunology. San Diego: Academic Press, 1989, pp. 167–169 (note 2)
Fleck, L. Genesis and development of a scientific fact. Bradley, F. and Trenn, T.J., Transl. Chicago: University of Chicago Press, 1979.
Witebsky, E., Rose, N.R., Terplan, K., Paine, J.R., Egan, R.W Chronic thyroiditis and autoimmunization. JAMA 164: 1439–1447, 1957.
Cruse, J.M., Whitcome, D., and Lewis, R.E. Autoimmunity — historical perspective. Concepts Immunopathol. 1: 34–35, 1985 (note 2).
Cruse, J.M., Whitcome, D., and Lewis, R.E. Autoimmunity — historical perspective. Concepts Immunopathol. 1: 32–71, 1985
60b. Beutner, E.H., Chorzelski, T.P., Binder, W.L. Nature of autoimmunity: pathologic versus physiologic responses and a unifying concept. In Beutner, E.H., Chorzelski, T.P., and Bean, R. Immunopathology of the Skin 2nd ed. New York, Wiley, 1979, pp. 147–180. (note 4).
Root-Bernstein, R.S. Protein replication by amino acid pairing. J. Theor. Biol. 100, 99–106, 1983
Mekler, L.B. Antibody formation. Nature 215, 481–483, 1967; Cook, N.D. The case for reverse translation. J. Theor. Biol. 64, 113–135, 1977.
Cohen, Cohen, I.R. The self, the world, and autoimmunity. Sci. Am. 52–61, April 1988 (note 10).
As quoted by Burnet, F.M. Changing Patterns: An Atypical Autobiography Melbourne: Heinemann, 1968, pp. 11–12.
Root-Bernstein, R.S. Multiple antigen mediated autoimmunity (MAMA) in AIDS: a possible model for postinfectious autoimmunity. Res. Immunol. (Institute Pasteur), 141, 815–838, 1990, pp. 44–47 (note 46)
Kuhn, T.S. The Structure of Scientific Revolutions. Chicago: University of Chicago Press, 1959.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Kluwer Academic Publishers
About this chapter
Cite this chapter
Root-Bernstein, R.S. (1991). Self, Nonself and the Paradoxes of Autoimmunity. In: Tauber, A.I. (eds) Organism and the Origins of Self. Boston Studies in the Philosophy of Science, vol 129. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3406-4_8
Download citation
DOI: https://doi.org/10.1007/978-94-011-3406-4_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-1185-0
Online ISBN: 978-94-011-3406-4
eBook Packages: Springer Book Archive